Outcomes of patients with Severe Acute Respiratory Infections (SARI) admitted to the intensive care unit: Results from the Egyptian Surveillance Study 2010-2014
Keywords:
Clinical, outcomes, viral, SARI, ICU, Egypt, surveillanceAbstract
Background: Few data exist for respiratory viral infections in Egyptian patients. We describe the outcomes of hospitalized Egyptian patients with severe acute respiratory infections (SARI) admitted to the ICU. Methods: A prospective study in which all hospitalized patients meeting the WHO case definition for SARI and admitted to the ICU, during the period 2010–2014, were enrolled. Samples were tested using RT-PCR for influenza A, B, respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenza virus, adenovirus, bocavirus, enterovirus, and rhinovirus. Data were analyzed to study the clinical features of SARI-ICU patients and which pathogens are related to severe outcomes. Associated comorbidities were evaluated using Charlson Age-Comorbidity Index (CACI). Results: Of 1075 patients with SARI, 219 (20.3%) were admitted to the ICU. The highest rates were reported for RSV (37%). SARI-ICU patients had higher rates of hospital stay, pneumonia, respiratory failure, ARDS, and mortality. Multivariate logistic regression analysis identified associated respiratory disorders (p=0.001), radiological abnormalities (p=0.023), and longer hospital stay (p=0.005) as risk factors for severe outcomes. Conclusions: This surveillance study showed that 20% of hospitalized Egyptian patients with viral SARI needed ICU admission. SARI-ICU patients had higher rates of hospital stay, pneumonia, respiratory failure, ARDS, and mortality. Higher comorbidity index scores, radiological abnormalities, and longer hospital stay are risk factors for severe outcomes in SARI-ICU patients in our locality.
References
World Health Organization. WHO pandemic influenza draft protocol for rapid response and containment, 2006. WHO, Geneva.
World Health Organization. Chapter 7: a Cough or Difficulty Breathing. Handbook IMCI Integrated management of childhood illness. Available from: https://apps.who.int/iris/handle/10665/42939
World Health Organization. WHO global technical consultation: global standards and tools for influenza surveillance. Available from: https://www.who.int/influenza/resources/documents/technical_consultation/en/
World Health Organization. WHO surveillance case definitions for ILI and SARI. 2014. Available from: https://www.who.int/influenza/surveillance_monitoring/ili_sari_surveillance_case_definition/en/
Al-Toum R, Bdour S, Ayyash H. Adenovirus infections in Jordanian hospitalized pediatric patients: Prevalence and clinical features. Jordan Med J 2009;43:171-9.
El Kholy AA, Mostafa NA, El-Sherbini SA, Ali AA, Ismail RI, Magdy RI,et al. Morbidity and outcome of severe respiratory syncytial virus infection. Pediatr Int 2013;55:283-8.
El Kholy AA, Mostafa NA, Ali AA, El-Sherbini SA, Ismail RI, Magdy RI, et al. Risk factors of prolonged hospital stay in children with viral severe acute respiratory infections. J Infect Dev Ctries 2014;8:1285-93.
Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011;377:1264-75.
Remolina YA, Ulloa MM, Vargas H, Díaz L, Gómez SL, Saavedra A, et al. Viral infection in adults with severe acute respiratory infection in Colombia. PLoS One 2015;10e0143152.
Sakr Y, Ferrer R, Reinhart K, et al. The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. Intensive Care Med 2016;42:817-88.
Hatem A, Mohamed S, Abu Elhassan UE, Ismael EAM, Rizk MS, El-Kholy A, El-Harras M, et al. Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): Results from the Egyptian Surveillance Study 2010-2014. Multidiscip Respir Med 2019:14:11. doi: 10.1186/s40248-019-0174-7
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.
World Health Organization. WHO information for molecular diagnosis of influenza virus - update. Available from: https://www.who.int/influenza/gisrs_laboratory/molecular_diagnosis/en/
Horton KC, Dueger EL, Kandeel A, Abdallat M, El-Kholy A, Al- S, al. Viral etiology, seasonality and severity of hospitalized patients with severe acute respiratory infections in the Eastern Mediterranean Region, 2007-2014. PLoS One 2017;12:e0180954.
Meerhoff TJ, Simaku A, Ulqinaku D, Torosyan L, Gribkova N, Shimanovich V, et al. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region–an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases. BMC Infect Dis 2015;15:1.
Moesker FM, van Kampen JJ, van Rossum AMC, de Hoog M, Koopmans MPG, Osterhaus ADME, Fraaij PLA. Viruses as sole causative agents of severe acute respiratory tract infections in children. PLoS One 2016;11:e0150776.
Wansaula Z, Olsen SJ, Casal MG, Golenko C, Erhart LM, Kammerer P, et al. Surveillance for severe acute respiratory infections in Southern Arizona, 2010-2014. Influenza Other Respir Viruses 2016;10:161-9.
Breiman RF, Cosmas L, Njenga MK, Williamson J, Mott JA, Katz MA, et al. Severe acute respiratory infection in children in a densely populated urban slum in Kenya, 2007-2011. BMC Infect Dis 2015;15:95.
Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, et al. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One 2015;10:e0118884.
Henrickson KJ, Hall CB. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007;26: S36-40.
Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98.
Falsey AR, Criddle MC, Walsh EE. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J Clin Virol 2006;35:46-50.
Hasegawa K, Jartti T, Mansbach JM, Laham FR, Jewell AM, Espinola JA, et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: Multicenter cohort studies in the United States and Finland. J Infect Dis 2014;211:1550-9.
Jansen RR, Wieringa J, Koekkoek SM, Visse CE, Pajkrt D, Molenkamp R, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 2011;49:2631-–6.
Adams O, Weis J, Jasinska K, Vogel M, Tenenbaum T. Comparison of human metapneumovirus, respiratory syncytial virus and rhinovirus respiratory tract infections in young children admitted to hospital. J Med Virol 2015;87:275-80.
Oshansky CM, Gartland AJ, Wong SS, Jeevan T, Wang D, Roddam PL, et al. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am J Respir Crit Care Med 2014;189:449-62.
Vandini S, Bottau P, Faldella G, Lanari M. Immunological, viral, environmental, and individual factors modulating lung immune response to respiratory syncytial virus. Biomed Res Int 2015;2015:875723.
Viasus D, Paño-Pardo JR, Cordero E, Campins A, López-Medrano F, Villoslada A, et al. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. J Infect 2011;62:193-9.
Published
Issue
Section
License
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
